Ajax-Loading

Astellas Pharma Inc. - Other Current Liabilities

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Other-Current-Liabilities" stands at 610.63 Billion Japanese Yens as of 06/30/2025.

As of the end of Astellas Pharma Inc.'s first quarter, the item "Other Current Liabilities" stands at 610.63 Billion JPY. This represents an increase of 0.56 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.52 percent compared to the value the year prior.
The 1 year change in percent is -2.52.
The 3 year change in percent is 7.23.
The 5 year change in percent is 21.43.
The 10 year change in percent is 230.71.

The Serie's long term average value is 316.37 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 93.01 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2011, to it's latest available value, on 06/30/2025, is +670.98%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 06/30/2025, is -2.52%.

Other Current Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Current Liabilities905,699,262,464.00
LogoJohnson & Johnson - Other Current Liabilities486,508,953,600.00
LogoAbbVie Inc - Other Current Liabilities399,570,305,024.00
LogoRoche Holding AG - Other Current Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Other Current Liabilities280,205,508,085.11